EFFECT OF ANTICANCER DRUGS ON PRIMARY CELL CULTURES OF PATIENTS WITH COLORECTAL CANCER
- Authors: Golyasnaya NV1, Ivanov Y.V2, Zhizhin NS2
-
Affiliations:
- Институт экологии и генетики микроорганизмов УрО РАН
- ФГБУ ФНКЦ ФМБА России
- Issue: Vol 7, No 2 (2016)
- Pages: 21-26
- Section: Articles
- URL: https://journals.rcsi.science/clinpractice/article/view/8094
- DOI: https://doi.org/10.17816/clinpract7221-26
- ID: 8094
Cite item
Full Text
Abstract
The goal of the research is to estimate the effect of 5-Fluorouracil, Cisplatin, Tomudex, Leucovorin and their combinations on colorectal cancer cells in vitro. Cell response to the effect of cytotoxic compounds and immunomodulator was estimated by the change in chromosomal aberrations, cell growth rate, proliferative activity and colonyforming unit. It was detected that antineoplastic drugs affected the mutagenesis and fission rate of cultured cells.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
N V Golyasnaya
Институт экологии и генетики микроорганизмов УрО РАН
Email: golasnaya@mail.ru
ст.н.с. лаборатории химического мутагенеза Института экологии и генетики микроорганизмов УрО РАН,к.б.н.
Yu V Ivanov
ФГБУ ФНКЦ ФМБА Россиизаведующий отделением хирургии ФГБУ ФНКЦ ФМБА России, д.м.н.,профессор.
N S Zhizhin
ФГБУ ФНКЦ ФМБА России
Email: gigin2000@mail.ru
врач-колопроктолог, руководитель клиники лазерной проктологии ФГБУ ФНКЦ ФМБА России,к.м.н.
References
- Барсуков Ю.А., Кныш В.И. Современные возможности лечения колоректального рака. Современная онкология. 2014. Т. 8. № 2. С. 7-16.
- Имянитов Е.Н. Клинико-молекулярные аспекты колоректального рака: этиопатогенез, профилактика, индивидуализация лечения. Практическая онкология. 2015. № 6. С. 65-70.
- Клаус Дж. Лимфоциты. Методы. M. 2006.
- Cai G., Xu Y., Lu H. Clinicopathologic and molecular features of sporadic microsatelliteand chromosomal-stable colorectal cancers. Int J Colorectal Dis. 2016. V. 23. N 4. P. 365-373.
- Cheng K.C., Loeb L.A. Hereditary colorectal cancer. J Clin Oncol. 2014. V. 22. N 16. P. 3284-3292.
- Davies R.J., Miller R., Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat. Rev. Cancer. 2015. V. 5. P. 199-209.
- Deisboeck T.S., Berens M.E., Kansal A.R. Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumor spheroid model. Cell. Prolif. 2014. V. 34. N 1. Р. 115-134.
- DiPersio J.F., Brennan J.K.,Lichtman M.A. Human cell lines that elaboratecolony-stimulating activity for the marrow cells of man and other species. Exp. Hematol. 2013. V. 6. N 8. P. 661-672.
- Fishel R., Lescoe M., Rao M. The humanmutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 2013. V. 75. N 3. P. 1027-1038.
- Genschel J. Littman S., Drummond J.,Modrich P. Isolation of MutS beta from human cells and comparison of the mismatch repair specificities of MutS beta and MutS alpha.J. Biol. Chem. 2016. V. 273. N 31. P. 19895-19901.
- Giavazzi R., Campbell D., Jessup J. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. Cancer Res. 2015. V. 46. N 5. Р. 1928-1933.
- Lievre A., Laurent-Puig P. Molecular biology in clinical cancer research: the example of digestive cancers. Rev. Epidemiol. Sante Publique. 2015. V. 53. N 3. P. 267-282.
- Vogel I., Soeth E., Ruder C. Disseminated tumor cells in the blood and/or bone marrow of patients with colorectal carcinoma are an independent prognostic factor. Annual Oncol. 2014. V. 11. N 4. P. 43-183.
- Worthley D.L., Whitehall V.L., Spring K.J. Colorectal carcinogenesis: Road maps to cancer. World J. Gastroenterol. 2012. Vol. 3.N 28.P.3784-3791.